The safety and efficacy of alfentanil-based induction in bronchoscopy sedation: A randomized, double-blind, controlled trial

Chung Hsing Hsieh, Ting Yu Lin, Tsai Yu Wang, Chih Hsi Kuo, Shu Min Lin, Han Pin Kuo, Yu Lun Lo

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Alfentanil in combination with propofol produces a synergistic sedative effect in patients undergoing flexible bronchoscopy (FB). However, the use of this combination is controversial due to the risk of cardiopulmonary depression. The aim of this study was to evaluate the proper induction regimen of alfentanil in propofol target-controlled infusion for FB sedation. Methods:One hundred seventy-three patients were assigned randomly into 5 regimens: Group 1 and 2, alfentanil 2.5 and 5mg/kg, respectively, immediately before propofol administration; Group 3 and 4, alfentanil 2.5 and 5mg/kg, respectively, 2minutes before propofol administration; and Group 5, propofol administration alone to achieve the observer assessment of alertness and sedation scale 3∼2. The bronchoscopists, physicians in charge of sedation, and patients were blind to the regimens. Adverse events, drug dose, induction, procedure and recovery time, cough severity, and propofol injection related pain were recorded. Results: The patients in groups 2 and 4 required a lower dose of propofol (P=0.031 and 0.019, respectively) and shorter time (P=0.035 and 0.010) than group 5 for induction. Patients in group 2 experienced more hypoxemia than those in group 5 during induction (P=0.031). The physician in charge of sedation scored a lower severity of cough in the patients in group 4 than in groups 3 and 5. There were no differences in terms of propofol injection related pain among the groups. Conclusion: Alfentanil 5mg/kg given immediately before propofol infusion cannot be recommended. Further study is required to define conclusions about alfentanil 2.5 and 5mg/kg because of the low power rating of subgroup in the present study.

Original languageEnglish
Article numbere5101
JournalMedicine (United States)
Volume95
Issue number43
DOIs
Publication statusPublished - Jan 1 2016
Externally publishedYes

Fingerprint

Alfentanil
Bronchoscopy
Propofol
Safety
Cough
Physicians
Pain
Injections
Drug-Related Side Effects and Adverse Reactions
Hypnotics and Sedatives
Depression

Keywords

  • Alfentanil
  • Bronchoscopy
  • Hypotension
  • Hypoxemia
  • Propofol

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The safety and efficacy of alfentanil-based induction in bronchoscopy sedation : A randomized, double-blind, controlled trial. / Hsieh, Chung Hsing; Lin, Ting Yu; Wang, Tsai Yu; Kuo, Chih Hsi; Lin, Shu Min; Kuo, Han Pin; Lo, Yu Lun.

In: Medicine (United States), Vol. 95, No. 43, e5101, 01.01.2016.

Research output: Contribution to journalArticle

Hsieh, Chung Hsing ; Lin, Ting Yu ; Wang, Tsai Yu ; Kuo, Chih Hsi ; Lin, Shu Min ; Kuo, Han Pin ; Lo, Yu Lun. / The safety and efficacy of alfentanil-based induction in bronchoscopy sedation : A randomized, double-blind, controlled trial. In: Medicine (United States). 2016 ; Vol. 95, No. 43.
@article{4d940b53cc1e468eac4febe5a51e4d79,
title = "The safety and efficacy of alfentanil-based induction in bronchoscopy sedation: A randomized, double-blind, controlled trial",
abstract = "Background: Alfentanil in combination with propofol produces a synergistic sedative effect in patients undergoing flexible bronchoscopy (FB). However, the use of this combination is controversial due to the risk of cardiopulmonary depression. The aim of this study was to evaluate the proper induction regimen of alfentanil in propofol target-controlled infusion for FB sedation. Methods:One hundred seventy-three patients were assigned randomly into 5 regimens: Group 1 and 2, alfentanil 2.5 and 5mg/kg, respectively, immediately before propofol administration; Group 3 and 4, alfentanil 2.5 and 5mg/kg, respectively, 2minutes before propofol administration; and Group 5, propofol administration alone to achieve the observer assessment of alertness and sedation scale 3∼2. The bronchoscopists, physicians in charge of sedation, and patients were blind to the regimens. Adverse events, drug dose, induction, procedure and recovery time, cough severity, and propofol injection related pain were recorded. Results: The patients in groups 2 and 4 required a lower dose of propofol (P=0.031 and 0.019, respectively) and shorter time (P=0.035 and 0.010) than group 5 for induction. Patients in group 2 experienced more hypoxemia than those in group 5 during induction (P=0.031). The physician in charge of sedation scored a lower severity of cough in the patients in group 4 than in groups 3 and 5. There were no differences in terms of propofol injection related pain among the groups. Conclusion: Alfentanil 5mg/kg given immediately before propofol infusion cannot be recommended. Further study is required to define conclusions about alfentanil 2.5 and 5mg/kg because of the low power rating of subgroup in the present study.",
keywords = "Alfentanil, Bronchoscopy, Hypotension, Hypoxemia, Propofol",
author = "Hsieh, {Chung Hsing} and Lin, {Ting Yu} and Wang, {Tsai Yu} and Kuo, {Chih Hsi} and Lin, {Shu Min} and Kuo, {Han Pin} and Lo, {Yu Lun}",
year = "2016",
month = "1",
day = "1",
doi = "10.1097/MD.0000000000005101",
language = "English",
volume = "95",
journal = "Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries",
issn = "0025-7974",
publisher = "Lippincott Williams and Wilkins",
number = "43",

}

TY - JOUR

T1 - The safety and efficacy of alfentanil-based induction in bronchoscopy sedation

T2 - A randomized, double-blind, controlled trial

AU - Hsieh, Chung Hsing

AU - Lin, Ting Yu

AU - Wang, Tsai Yu

AU - Kuo, Chih Hsi

AU - Lin, Shu Min

AU - Kuo, Han Pin

AU - Lo, Yu Lun

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Background: Alfentanil in combination with propofol produces a synergistic sedative effect in patients undergoing flexible bronchoscopy (FB). However, the use of this combination is controversial due to the risk of cardiopulmonary depression. The aim of this study was to evaluate the proper induction regimen of alfentanil in propofol target-controlled infusion for FB sedation. Methods:One hundred seventy-three patients were assigned randomly into 5 regimens: Group 1 and 2, alfentanil 2.5 and 5mg/kg, respectively, immediately before propofol administration; Group 3 and 4, alfentanil 2.5 and 5mg/kg, respectively, 2minutes before propofol administration; and Group 5, propofol administration alone to achieve the observer assessment of alertness and sedation scale 3∼2. The bronchoscopists, physicians in charge of sedation, and patients were blind to the regimens. Adverse events, drug dose, induction, procedure and recovery time, cough severity, and propofol injection related pain were recorded. Results: The patients in groups 2 and 4 required a lower dose of propofol (P=0.031 and 0.019, respectively) and shorter time (P=0.035 and 0.010) than group 5 for induction. Patients in group 2 experienced more hypoxemia than those in group 5 during induction (P=0.031). The physician in charge of sedation scored a lower severity of cough in the patients in group 4 than in groups 3 and 5. There were no differences in terms of propofol injection related pain among the groups. Conclusion: Alfentanil 5mg/kg given immediately before propofol infusion cannot be recommended. Further study is required to define conclusions about alfentanil 2.5 and 5mg/kg because of the low power rating of subgroup in the present study.

AB - Background: Alfentanil in combination with propofol produces a synergistic sedative effect in patients undergoing flexible bronchoscopy (FB). However, the use of this combination is controversial due to the risk of cardiopulmonary depression. The aim of this study was to evaluate the proper induction regimen of alfentanil in propofol target-controlled infusion for FB sedation. Methods:One hundred seventy-three patients were assigned randomly into 5 regimens: Group 1 and 2, alfentanil 2.5 and 5mg/kg, respectively, immediately before propofol administration; Group 3 and 4, alfentanil 2.5 and 5mg/kg, respectively, 2minutes before propofol administration; and Group 5, propofol administration alone to achieve the observer assessment of alertness and sedation scale 3∼2. The bronchoscopists, physicians in charge of sedation, and patients were blind to the regimens. Adverse events, drug dose, induction, procedure and recovery time, cough severity, and propofol injection related pain were recorded. Results: The patients in groups 2 and 4 required a lower dose of propofol (P=0.031 and 0.019, respectively) and shorter time (P=0.035 and 0.010) than group 5 for induction. Patients in group 2 experienced more hypoxemia than those in group 5 during induction (P=0.031). The physician in charge of sedation scored a lower severity of cough in the patients in group 4 than in groups 3 and 5. There were no differences in terms of propofol injection related pain among the groups. Conclusion: Alfentanil 5mg/kg given immediately before propofol infusion cannot be recommended. Further study is required to define conclusions about alfentanil 2.5 and 5mg/kg because of the low power rating of subgroup in the present study.

KW - Alfentanil

KW - Bronchoscopy

KW - Hypotension

KW - Hypoxemia

KW - Propofol

UR - http://www.scopus.com/inward/record.url?scp=84995932357&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995932357&partnerID=8YFLogxK

U2 - 10.1097/MD.0000000000005101

DO - 10.1097/MD.0000000000005101

M3 - Article

C2 - 27787363

AN - SCOPUS:84995932357

VL - 95

JO - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries

JF - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries

SN - 0025-7974

IS - 43

M1 - e5101

ER -